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AbstrAct
background  Brief interventions (BIs) delivered in 
primary care have been shown to be effective in 
reducing risky drinking, but implementation is limited. 
Facilitated access to a digital application offers a novel 
alternative to face-to-face intervention, but its relative 
effectiveness is unknown. 
Methods  Primary care-based, non-inferiority, 
randomised controlled trial comparing general 
practitioner (GP) facilitated access to an interactive 
alcohol reduction website (FA) with face-to-face BI for 
risky drinking. Patients screening positive on the short 
Alcohol Use Disorders Identification Test (AUDIT-C) were 
invited to participate in the trial. Assessment at baseline, 
3 months and 12 months was carried out using AUDIT 
and EQ-5D-5L questionnaires. 
Findings  58 participating GPs approached 9080 
patients of whom 4529 (49.9%) logged on, 3841 
(84.8%) undertook screening, 822 (21.4%) screened 
positive and 763 (19·9%) were recruited. 347 (45.5%) 
were allocated to FA and 416 (54.5%) to BI. At 3 months, 
subjects in FA group with an AUDIT score of ≥8 reduced 
from 95 (27.5%) to 85 (26.8%) while those in BI group 
increased from 123 (20.6%) to 141 (37%). Differences 
between groups were principally due to responses 
to AUDIT question 10. Analysis of primary outcome 
indicated non-inferiority of FA compared with BI, and 
prespecified subgroup analysis indicated benefits for 
older patients and those with higher levels of computer 
literacy and lower baseline severity. Additional analyses 
undertaken to take account of bias in response to AUDIT 
question 10 failed to support non-inferiority within the 
prespecified 10% boundary. 
Interpretation Prespecified protocol-driven analyses 
of the trial indicate that FA is non-inferior to BI; 
however, identified bias in the outcome measure and 
further supportive analyses question the robustness 
of this finding. It is therefore not possible to draw firm 
conclusions from this trial, and further research is needed 
to determine whether the findings can be replicated using 
more robust outcome measures. 
trial registration number NCT01638338; Results.
IntroductIon
Alcohol is the third leading cause of diseases 
and premature death globally1 and accounts 
for 3.8% of deaths and 4.6% of disability-ad-
justed life years.2 Brief interventions (BIs) 
delivered in primary healthcare settings 
have been demonstrated repeatedly to be 
effective in reducing hazardous and harmful 
drinking.3 However, barriers prevent their 
widespread implementation, including 
insufficient training, lack of resources and 
constraints in time.4 Digital applications 
including websites and apps that are based 
on behaviour change techniques may be 
helpful in overcoming these barriers,5 6 and 
clinicians may actively encourage patients to 
use approved applications through a process 
known as facilitated access. Initially adopted 
primarily for the management of patients 
with mental health problems including 
depression and anxiety, facilitated access 
has been extended to digital applications 
for addictive behaviours including smoking 
cessation and alcohol screening, and to 
health promotion and the management of 
some long-term conditions.7 8 
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Research
strengths and limitations of this study
 ► The trial evaluated a potentially important 
development for primary care, namely the use by 
general practitioners of facilitated access to a digital 
application as an alternative to traditional face-to-
face consultation, in this case for patients with risky 
drinking.
 ► All components of the trial were delivered online 
with the exception of the face-to-face intervention, 
thus, reducing the cost of the trial, allowing real-
time tracking of the findings, ensuring consistency 
of conduct and avoiding errors of transcription.
 ► Follow-up rates exceeded 90% at 3 months and 
80% at 12 months.
 ► Levels of hazardous and harmful drinking in trial 
participants were lower than anticipated.
 ► Probable bias in the brief intervention group indicates 
that caution should be exercised in interpreting the 
main findings.
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Figure 1 Screenshot showing tailored feedback on Alcohol Use Disorders Identification Test with general practitioner 
personalisation (translated from original Italian).
Facilitated access offers a novel alternative to face-to-
face BI for risky drinking, but it is not known whether 
it is as effective. A review of trials of computer-based 
interventions offered to college drinkers found them 
to be more effective than no treatment and as effec-
tive as alternative treatment approaches.9 A systematic 
review of electronic interventions for risky drinkers 
concluded that there were significant reductions in 
weekly alcohol consumption between intervention and 
control conditions between 3 months and less than 
12-month follow-up, indicating this may be an effective 
intervention.10
A review of digital and computer-based alcohol inter-
vention programmes promoted in primary care settings 
identified 15 small-scale trials of which 9 were associated 
with a reduction in alcohol use at follow-up.11 The indi-
cations from these studies about the likely effectiveness 
and cost-effectiveness of internet applications in primary 
care were generally positive, but firm conclusions could 
not be drawn because of limitations of sample size and 
study design. An adequately powered and appropriately 
designed trial was, therefore, required to provide more 
definitive evidence on the use of facilitated access as 
an alternative to face-to-face BI for the reduction of 
hazardous and harmful drinking and to indicate the 
potential for this approach to be adopted more gener-
ally in the management of health conditions by general 
practitioners (GPs). The research question addressed 
by the trial was ‘Is facilitated access to an interactive 
alcohol reduction website as effective in reducing 
hazardous and harmful drinking as face-to-face BI?’
Methods
study design
Primary care-based, non-inferiority, randomised 
controlled trial of BI for risky drinkers comparing GP 
facilitated access to an interactive alcohol reduction 
website (facilitated access) with standard face-to-face 
BI. With the exception of face-to-face intervention, all 
components of the trial were delivered online to patients 
following receipt of a brochure describing the website 
and providing a unique trial log-on number. Access to the 
website was via the healthy lifestyle portal of the official 
website of the Region of Friuli-Venezia Giulia (www. down-
yourdrink. org. uk/). GPs were recruited via the official 
register of the Friuli-Venezia Giulia region of Northern 
Italy. All participating GPs attended a 1-day training event 
including an overview of the trial and interactive sessions 
on the delivery of face-to-face BI using the principles of 
brief motivational interviewing. They were encouraged 
to familiarise themselves with the trial website and to use 
the menu-driven online GP personalisation facility to 
create their own tailored patient messages at up to four 
key points of the programme (see figure 1). They were 
also given brief guidance about how to actively encourage 
patients to access the website.
The protocol was approved by the Isontina Independent 
Local Health Unit Ethics Committee on 14 June 2012.12
Patients
All patients aged ≥18 years who attended the partici-
pating practices during the study period were eligible for 
the trial, but those known by the GPs to suffer from severe 
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Figure 2 Subject progress through the trial.
psychiatric disorder, alcohol dependence, serious visual 
impairment or terminal illness were excluded, as were 
those judged to have inadequate command of the Italian 
language.
randomisation and masking
Randomisation was at the individual level and was auto-
mated, concealed and undertaken online using software 
which generated randomisation with an allocation ratio 
1:1. There was no stratification or blinding.
Procedures
For the purposes of screening, GPs spoke briefly to eligible 
patients, gave them a trial brochure with a unique login 
code and actively encouraged them to access the trial 
website. Those who logged on were asked to complete the 
three-question short Alcohol Use Disorders Identification 
Test (AUDIT-C)13 and to provide consent for the result of 
the test to be sent to their practice. For the purposes of 
the trial, cut points of 4 for women and 5 for men were 
used to identify probable hazardous or harmful drinkers. 
Patients screening below the cut points received an online 
message advising that their responses indicated that 
their stated drinking patterns fell within the guidelines 
for sensible drinking. Those scoring at or above the cut 
points received a personalised online message from their 
GP advising that their stated drinking patterns indicated 
that they were likely to be at risk from their drinking and 
encouraging them to take part in the study. They were 
then invited to review the online patient information 
leaflet and to complete the consent module. Following 
consent, patients were invited to complete online ques-
tionnaires including a questionnaire seeking information 
on age, gender, level of education and occupation, the 
10-question AUDIT validated Italian version14 15 and the 
EQ-5D-5 L quality-of-life questionnaire, validated Italian 
version.16 Completion of baseline questionnaires was 
followed automatically by concealed online randomi-
sation to either facilitated access to the alcohol reduc-
tion website or to face-to-face BI. The alcohol reduction 
website was adapted from the Down Your Drink Website 
(http://www. downyourdrink. org. uk), details of which 
have been reported elsewhere.17 Country-specific infor-
mation for Italy such as the recommended guidelines for 
alcohol intake, definitions of standard drinks and alco-
hol-related laws were included in the website. The website 
was further adapted to include a menu-driven facility 
which enabled the participating GPs to create person-
alised automated tailored online messages for their 
patients. These were available at four key points in the 
programme, and included options to customise written 
text, add photographs and insert audio/video recorded 
messages.18 An example of a screenshot of tailored feed-
back with GP personalisation is shown in figure 1.
Patients allocated to facilitated access were directed 
to the opening page of the alcohol reduction website 
containing a personalised online message from their 
GP with tailored feedback about their responses to the 
AUDIT questionnaire. Further online messages empha-
sised the importance of adopting healthy drinking 
choices. They provided encouragement to spend at least 
15 min engaging with the alcohol reduction website, 
including making entries in the personal Thinking 
Drinking Record (TDR) about their assessment of costs 
and benefits of their current levels of drinking. An auto-
mated email was sent 1 week later encouraging further 
log on. Patients were also asked online to review their 
alcohol consumption and were invited to discuss their 
website experience when they next saw their GP.
Patients allocated to face-to-face BI were invited to check 
a box online which automatically generated an email to 
their GP requesting an appointment within the next 7–10 
days. GPs were instructed to offer a BI lasting 5–15 min 
based on the brief motivational interview.19 Non-attenders 
were offered up to three additional appointments.
Follow-up assessment
Follow-up took place 3 and 12 months after randomisa-
tion and a series of approaches were adopted to optimise 
response rates. In the first instance, each patient in the 
trial received an automated email requesting them to 
login to the website to complete their assessment ques-
tionnaires. Failure to do so resulted in further automated 
emails at 1-week and 2-week intervals. Persistent failure 
was notified to the patient’s GP, who was asked to ensure 
that they were contacted by letter, phone or in person 
in order to complete their assessment. Where necessary, 
assessment was completed over the phone.
outcomes
The prespecified primary outcome measure was the 
proportion of hazardous or harmful drinkers as defined 
by a score of ≥8 points on the AUDIT questionnaire at 
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Table 1 Baseline characteristics
Item
Facilitated 
access n=346
Face-to-face 
n=415
Male (%) 214 (62.0) 255 (61.9)
Marital status (%)
  Single 95 (27.9) 116 (28.4)
  Married 208 (61.0) 247 (60.4)
  Separated 28 (8.2) 36 (8.8)
  Widowed 10 (2.9) 10 (2.4)
Ethnicity (%)
  Bengali 1 (0.3) 1 (0.25)
  Indian 1 (0.3) 2 (0.5)
  Italian 328 (98.2) 391 (97.8)
  North African 0 (0) 1 (0.25)
  Mixed race 1 (0.3) 1 (0.25)
  Black African 3 (0.9) 4 (1.0)
Familiarity with IT (%)
  Not familiar 58 (16.9) 62 (15.2)
  Fairly familiar 84 (24.5) 93 (22.8)
  Familiar 91 (26.5) 119 (29.2)
  Very familiar 110 (32.1) 134 (32.8)
Qualifications (%)
  None 2 (0.6) 2 (0.5)
  Elementary/junior school 112 (32.9) 126 (30.9)
  High school 174 (51.2) 184 (45.1)
  University 45 (13.2) 78 (19.1)
  Higher degree 7 (2.1) 18 (4.4)
Age, median (IQR) 49 (37–59) 50 (35–61)
No of children, median (IQR) 1 (0–2) 1 (0–2)
AUDIT-10, median (IQR) 5 (4–8) 6 (4–9)
Hazardous/harmful drinker 
(AUDIT ≥8) (%)
95 (27.5) 123 (29.6)
AUDIT: Alcohol Use Disorders Identification Test; 
Table 2 Engagement with alcohol reduction website by 
patients in facilitated access group (n=346)
Engagement variable Mean (SD) IQR
User logins/patient 1.2 (0.85) 1–1
User page views/patient 33.5 (75.17) 1–41
TDR* total submissions/patient 18.5 (22.54) 3–27
TDR* total records/patient 14.8 (16.53) 3–22
TDR* total pages/patient 6.9 (6.88) 2–10
*TDR, Thinker Drinker Record entries made by patients on website 
pages.
3-month follow-up.20 The secondary outcome measure 
was the EQ-5D quality of life questionnaire, validated 
Italian version for use in economic evaluations. Advice 
to seek additional medical advice was given online to all 
patients scoring >20 on the AUDIT. Regular checks of 
the quality of the data were carried out under the super-
vision of the research team. Data files generated by the 
patients’ interactions with the alcohol reduction website 
were stored securely on servers in accordance with EU 
regulations. The only identifiers were the unique login 
number. The files generated by the practices linking the 
unique login numbers to the patient identifiers were 
stored securely along with other clinical data in the prac-
tice and were accessible only to practice staff.
statistical analysis
Facilitated access was deemed not inferior to face-to-
face treatment at a one-sided α of 2.5% if the difference 
between the proportions of hazardous or harmful drinkers 
in the facilitated access group and the face-to-face BI 
group was below a specified absolute margin of non-in-
feriority of 10%. Assuming a reduction of 30% in the 
proportion of hazardous or harmful drinkers in the 
face-to-face BI group and allowing for an overall attri-
tion of 10% of patients in the trial, it was calculated that 
500 patients would be required in each group to give 
the trial 90% power (1-β) to reject the null hypothesis 
that facilitated access is inferior to face-to-face interven-
tion. Analyses were described in a statistical analysis plan 
completed before database lock. To assess the non-in-
feriority of facilitated access compared with face-to-face 
BI, the proportions of hazardous or harmful drinkers in 
each group were computed and compared using gener-
alised non-linear mixed models accounting for general 
practices as random effects in order to address possible 
therapist effects and other practice level clustering. 
Additional, prespecified, supportive analyses designed 
to provide further information about the trial outcomes 
were conducted as follows: Supportive 1=random inter-
cept term for practices and baseline values for hazardous 
or harmful drinkers; Supportive 2=included a random 
residual term in replacement for the generalised random 
intercept term and baseline values for hazardous/
harmful drinkers; Supportive 3=AUDIT score as a contin-
uous outcome, including the baseline AUDIT score as 
a patient level explanatory variable, with generalised 
random intercept terms for GP practices.
Post hoc analyses were designed to address the unex-
pected finding that less than 30% of the participants were 
classified at baseline as hazardous or harmful drinkers by 
a score of ≥8 points on AUDIT, and the unexpected rise 
at follow-up in the proportions of patients in the face-to-
face BI group scoring ≥8 points on AUDIT. Analysis was 
therefore carried out for the 3 months principal outcome 
measure on the basis of subjects who were and were not, 
classified as hazardous or harmful drinkers at baseline, 
and additionally by removing the final question of the 
AUDIT which may have introduced bias favouring the 
experimental condition. All calculations were performed 
on the basis of intention to treat. An independent trial 
steering committee oversaw the general conduct of the 
trial and undertook data monitoring.
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Table 3 Number of risky drinkers at baseline, 3 and 12 
months by randomised condition
Time period, n in 
follow-up Face-to-face, n (%) Facilitated, n (%)
Baseline, n=761 123 (29.6) 95 (27.5)
3 months, n=698 141 (37.1) 85 (26.8)
12 months, n=620 88 (26.3) 71 (24.9)
Table 4 Primary analysis and supportive analyses
Analysis Estimate
Lower 
95% CI
Upper 
95% CI p-Value
Primary—proportion 
of hazardous or 
harmful drinkers (OR) 0.63 0.45 0.89 0.008
Supportive analysis 
1* (OR) 0.62 0.43 0.90 0.012
Supportive analysis 
2† (OR) 0.61 0.42 0.88 0.009
Supportive analysis 
3‡ (OR) −0.17 −0.58 0.25 0.43
*Proportion of hazardous or harmful drinkers; including baseline 
values for risky drinkers and random intercept term for practice.
†Including a random residual term in replacement for the 
generalised random intercept term for practice and baseline values 
for risky drinkers.
‡Alcohol Use Disorders Identification Test-10 score as a 
continuous outcome, including the baseline score as a patient level 
explanatory variable, with generalised random intercept terms for 
general practitioner practices.
Health economic analysis was undertaken to evaluate 
the cost-effectiveness of facilitated access to a website for 
hazardous drinkers compared with face-to-face BI, and 
the findings are reported in a separate paper.21
results
The trial was conducted in two phases—a pilot phase 
involving 11 GPs who recruited 89 subjects between 14 
January 2013 and 31 May 2013,1and the main trial phase 
involving 58 GPs who recruited 674 subjects between 20 
January 2014 and 31 August 2014. The trial design was 
identical in both phases. Brochures were distributed to a 
total of 9080 patients across the 58 practices, and resulted 
in 4529 (49.9%) patients logging on to the healthy life-
style website. Of these, 3841 (84.5%) undertook screening 
with the AUDIT-C and 822 (21.4%) screened positive. Of 
the screen positives, 763 (92.8%) were recruited to the 
trial, following consent, completion of baseline measures 
and randomisation. The minimum number of subjects 
recruited per practice was 1 and the maximum 89. The 
median number of subjects recruited per practice was 10 
and the IQR was 3–19.
Figure 2 describes the progress of the 763 subjects 
through the trial. Three hundred and forty-seven (45.5%) 
subjects were allocated to facilitated access to the alcohol 
reduction website and 416 (54.5%) to face-to-face BI. 
A total of 698 (91.5%) subjects completed the 3-month 
follow-up assessment and 620 (81.2%) the 12-month 
follow-up assessment. One subject was excluded due to 
inadvertent randomisation to both the intervention and 
control groups.
baseline characteristics
Table 1 describes the baseline characteristics of the 
subjects in each group. The median age of the subjects 
was 49 years (IQR 35–61) and 469 (61.9%) were men. 
The median score on the AUDIT was 5.5 (IQR 4–9). Two 
hundred and eighteen (28.6%) of the participants were 
classified at baseline as hazardous or harmful drinkers by 
a score of ≥8 points on the AUDIT.
engagement with face-to-face bI and facilitated access
Of the 416 patients allocated to face-to-face BI, 325 
(78.1%) were offered an appointment and 304 (73.1%) 
received a BI from their GP. Of the BIs, 171 (56.3%) were 
recorded as lasting less than 5 min, 87 (28.6) from 5 to 
10 min and 46 (15.1%) more than 10 min.
Table 2 describes engagement with the alcohol reduc-
tion website by the 342 patients in the facilitated access 
group as assessed in terms by numbers of logins, numbers 
of pages downloaded and the numbers of occasions 
on which an entry was made to the TDR section of the 
website.
AudIt scores
At baseline, 95 (27.5%) of the patients allocated to facil-
itated access were classified as hazardous or harmful 
drinkers by a score of ≥8 points on the AUDIT, compared 
with 123 (20.6%) of the patients allocated to face-to-face 
BI.
The numbers (%) of risky drinkers at the three assess-
ment points of the trial are shown in table 3.
In the patients assessed at 3 months, the number in 
this category in the facilitated access group reduced 
to 85 (26.8%) while in the face-to-face BI group it rose 
unexpectedly to 141 (37%), dropping at 12 months 
to 88 (26.3%). The difference at 3 months was largely 
accounted for by responses to AUDIT question 10: “Has 
a relative or friend, doctor or other health worker been 
concerned about your drinking or suggested that you cut 
down?”
Prespecified analyses
Table 4 describes the results for the prespecified anal-
ysis of the main outcome at 3 months and the additional 
supportive analyses.
Analysis of the primary outcome, difference in the odds 
of hazardous and harmful drinkers, shows statistically 
significant benefit for facilitated access compared with 
face-to-face BI. This is replicated in the additional prespec-
ified analyses and in all cases non-inferiority for facilitated 
access was demonstrated. Figure 3 describes the effects 
and interactions for the prespecified subgroups. There 
was a significant interaction for age, and some indication 
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Figure 3 Primary outcome—prespecified subgroup analyses.
Table 5 Twelve-month results—difference in hazardous/
harmful drinkers and mean AUDIT-10
Analysis Estimate
Lower 
95% CI
Upper 
95% CI p Value
Hazardous/harmful 
drinkers (OR) 0.943 1.432 0.621 0.784
Mean AUDIT-10 −0.3126 −0.8159 0.1906 0.2229
AUDIT-10, Alcohol Use Disorders Identification Test-10.
Table 6 Hazardous/harmful drinking at 3 months by 
hazardous/harmful drinking at baseline
Analysis Estimate
Lower 
95% CI
Upper 
95% CI p Value
Not hazardous/
harmful drinkers at 
baseline n=545
(OR)
0.476 0.289 0.782 0.004
Hazardous/harmful 
drinkers at baseline 
n=218 (OR)
0.772 0.431 1.383 0.382
Test for interaction between the groups, p=0.192.
of an interaction effect for computer literacy and baseline 
severity.
Table 5 describes the results of the analyses at 12 months 
on the proportion of hazardous or harmful drinkers per 
group, and the difference in mean AUDIT scores. The 12 
months OR for hazardous or harmful drinking demon-
strated non-inferiority of facilitated access compared with 
face-to-face BI, but non-inferiority was not demonstrated 
for the mean AUDIT scores at this time point.
Post hoc analyses
Table 6 shows the findings of post hoc analysis on the 
subsets of participants who were and were not hazardous/
harmful drinkers at baseline. The analysis did not support 
non-inferiority of facilitated access at 3-month follow-up 
for those with hazardous/harmful drinking at baseline.
Table 7 shows the proportions of participants classi-
fied as hazardous/harmful drinkers at 3 months and 
12 months using a cut point of >7 on the AUDIT ques-
tionnaire with question 10 removed.
Table 8 shows the results of further continuous and 
categorical analyses based on the AUDIT-C questions. 
Neither analysis supported non-inferiority of facilitated 
access.
eQ-5d
The results of the EQ-5D are reported in a separate paper 
(Hunter et al, Randomised non-inferiority trial of primary 
care-based facilitated access to an alcohol reduction 
website: cost effectiveness analysis bmjopen in pressman-
uscript ID: bmjopen-2016–0 14 577).
dIscussIon
As far as we are aware, this is the first trial comparing 
effectiveness of facilitated access by GPs to an alcohol 
reduction website with delivery of face-to-face BI. It has 
demonstrated that this approach can be successfully 
implemented in general practice, with 58 participating 
GPs each providing facilitated access to an average of 
more than 150 patients, and nearly half of the patients 
subsequently following their GP’s advice to log on and 
undertake screening. Furthermore, the great majority 
of patients randomised to facilitated access to the 
website went on to engage actively, downloading several 
pages and making multiple entries. The ODHIN trial 
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Table 7 Proportions of hazardous/harmful drinking as 
defined by >7 points on Alcohol Use Disorders Identification 
Test with question 10 removed
Time period, n in 
follow-up Face-to-face, n (%) Facilitated, n (%)
Baseline, n=761 93 (22.4) 79 (22.8)
3 months, n=698 28 (7.4) 32 (10.1)
12 months, n=620 27 (8.1) 35 (12.3)
Table 8 Continuous and categorical analyses based on 
the Alcohol Use Disorders Identification Test (AUDIT-C) 
questions
Analysis Estimate
Lower 
95% CI
Upper 
95% CI p Value 
Risky drinkers on 
AUDIT-C (OR) 1.555 2.127 1.136 0.006
Difference in mean 
AUDIT-C score
−0.185 −0.396 0.027 0.087
AUDIT-C, Alcohol Use Disorders Identification Test-C. 
which tested the relative impact on GP screening and 
BI activity of providing access to an alcohol reduc-
tion website (eBI), financial incentives and education 
and training, found that eBI was not associated with 
increased rates of activity.22 However, the training and 
familiarisation with the website offered to the GPs was 
almost certainly less rigorous than in the EFAR-FVG 
trial.23 Furthermore, the organisation of general 
practice in the five countries where ODHIN trial was 
conducted may have been less favourable to GP facili-
tated access.
The trial has a number of limitations. Fewer partic-
ipants were recruited than the figure defined by the 
power calculation, and more importantly the AUDIT-C 
screening tool performed poorly as a predictor of 
hazardous or harmful drinking as defined by a score of 
≥8 points on the AUDIT. This meant that the trial popu-
lation included only a minority (29.6%) of hazardous/
harmful drinkers as defined by an AUDIT score of ≥8. 
The resultant threshold effect was almost certainly 
responsible at least in part for the only modest reduc-
tions seen in the proportions of hazardous/harmful 
drinkers in both groups. The use of AUDIT-C cut points 
of 5 for men and 4 for women would have been expected 
to lead to the inclusion of substantially higher propor-
tions of hazardous and harmful drinkers as defined by 
a score of 8 or more on the AUDIT.24 25 The AUDIT-C 
has also been validated in Italian populations and 
found to perform similarly.10 However a recent paper 
has suggested that higher cut points should be used to 
reliably identify risky drinkers.26 In addition, the statis-
tical analyses assumed a similar clustering effect for 
both treatment conditions at the practice level, through 
fitting practice level random effects. It could be argued 
that differences in the intervention could lead to 
difference in the clustering within practices; however, 
our assumption a priori, based on substantial relevant 
experience, was that shared practice characteristics 
were likely to be the dominant factors in our analysis. 
Given the overall nature of the results and their inter-
pretation, we have not undertaken further supportive 
analyses on this question.
The trial did not observe the scale of reduction in the 
proportions of hazardous or harmful drinkers in the 
patients following BI by their GPs which had informed 
our sample size calculation. Instead, there was a para-
doxical increase in the proportion of patients in the face-
to-face BI group categorised as hazardous or harmful 
drinkers at 3 months though this was not maintained 
at 12 months. We postulated that this was largely due 
to bias introduced by the final AUDIT question which 
asks about advice to reduce drinking from a healthcare 
professional, and might therefore be expected to elicit 
a positive response in the short-term following face-
to-face BI. This hypothesis was supported by failure to 
confirm non-inferiority when the final question was 
omitted in the post hoc analysis.
The main strengths of the study include the size of the 
study population, numbers of GPs involved, high levels 
of facilitated access activity and high follow-up rates at 
both 3 months (91.5%) and 12 months (81.2%). The 
use of the Internet to deliver all components of the 
trial with the exception of the face-to-face intervention 
for patients in the control group reduced the cost of 
the trial, ensured consistency of conduct of all phases, 
avoided errors of transcription and enabled real-time 
tracking of trial activity by the study team. Furthermore, 
there were no reported breaches of data security.
Analysis of all prespecified outcome measures demon-
strated evidence of non-inferiority for facilitated access 
versus face-to-face BI. On the face of it, this implies that 
a simple message given by the GP to the patient during 
facilitated access combined with provision of the log-on 
code for the alcohol reduction website was no less effec-
tive in prompting behavioural change than a 5–10 min 
BI delivered face-to-face. This is consistent with the 
findings of a number of studies, most notably the SIPS 
trial which found the outcomes in patients screening 
positive hazardous or harmful drinking provided with 
a patient information leaflet were no worse than for 
those given 5 min of structured brief advice or 20 min 
of brief lifestyle counselling.27 These findings are also 
consistent with much of the growing literature on the 
effectiveness of digital interventions indicating that 
users benefit from online alcohol interventions and 
that this approach may be particularly useful for groups 
less likely to access traditional alcohol-related services, 
such as women, young people and at-risk users.28
However, the reliability of the conclusions from the 
primary analyses is seriously called into question by the 
results of the post hoc analyses performed in order to 
deal with the presumptive evidence of response bias 
in the face-to-face group. When these were performed 
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using both a subset of the questions on the AUDIT 
omitting question 10 and the three questions of the 
AUDIT-C, the results no longer supported the conclu-
sion of non-inferiority of facilitated access. This raises 
real questions about the reliability of the trial’s main 
findings, and further research will be needed to 
determine whether these can be replicated. Alterna-
tive cut points on the screening AUDIT-C could be 
used to ensure the inclusion of greater proportions 
of hazardous/harmful drinkers in future studies, and 
an alternative outcome measure such as the timeline 
follow-back questionnaire29 could be used in order to 
avoid bias introduced by the AUDIT. It would also be 
helpful to replicate the trial in general practice settings 
involving larger clinical teams and greater numbers of 
registered patients. At least one such trial is currently 
underway in Catalunya, Spain.30 Additional study is also 
needed to improve understanding of the mechanisms 
underlying the impact of facilitated access and the 
conditions required to optimise it, including the role 
played by online GP personalisation.
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